• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体 C3dg 片段优于常规 C3 作为系统性红斑狼疮的诊断生物标志物。

The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.

机构信息

Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.

Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

Front Immunol. 2018 Mar 26;9:581. doi: 10.3389/fimmu.2018.00581. eCollection 2018.

DOI:10.3389/fimmu.2018.00581
PMID:29632534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5879092/
Abstract

INTRODUCTION/OBJECTIVES: In 2012, hypocomplementemia was included in the classification criteria of systemic lupus erythematosus (SLE). The suggested measurement of C3 or C4 often reflect disease activity poorly. Our objective was to establish an assay measuring C3dg, which is generated following complement activation, and to evaluate the assay in a cross-sectional SLE cohort.

METHOD

We included SLE patients ( = 169) and controls ( = 170) and developed a modified C3dg assay where C3dg fragments were separated from the large plasma proteins by polyethylene glycol (PEG), and the supernatant containing the C3dg fragment was used for analysis in an antibody-based sandwich-type assay. Gel permeation chromatography and western blotting were used to establish the optimal conditions for PEG precipitation.

RESULTS

16% PEG was optimal for separating C3dg from C3 and the larger protein fragments. The assay showed a high degree of stability when using EDTA plasma, and measurements correlated well with commercially available complement activation assays. SLE patients had higher concentrations in plasma of C3dg than controls ( < 0.05). ROC analysis showed that the C3dg activation fragment of C3 with an AUC of 0.96 (CI 0.94-0.98) was superior to C3 (AUC 0.52) in differentiating between patients and controls.

CONCLUSION

Our results present a modified assay for the measurement of C3dg. We demonstrate that C3dg was superior to conventional C3 measurements in discriminating SLE patients from controls. We suggest that C3dg should be considered as a complement activation measurement in the SLE classification criteria.

摘要

简介/目的:2012 年,低补体血症被纳入系统性红斑狼疮(SLE)的分类标准。C3 或 C4 的检测通常不能很好地反映疾病活动度。我们的目的是建立一种检测 C3dg 的方法,C3dg 是补体激活后产生的,并用该方法检测一个 SLE 横断面队列。

方法

我们纳入了 SLE 患者( = 169)和对照组( = 170),并开发了一种改良的 C3dg 检测方法,该方法通过聚乙二醇(PEG)将 C3dg 片段与大的血浆蛋白分离,并用抗体夹心型检测法分析上清液中的 C3dg 片段。凝胶渗透色谱和 Western blot 用于建立 PEG 沉淀的最佳条件。

结果

16%PEG 是分离 C3dg 与 C3 和较大蛋白片段的最佳浓度。该检测方法使用 EDTA 血浆时具有高度稳定性,并且与商业上可用的补体激活检测方法具有良好的相关性。SLE 患者的血浆 C3dg 浓度高于对照组( < 0.05)。ROC 分析表明,C3 的 C3dg 激活片段的 AUC 为 0.96(CI 0.94-0.98),优于区分患者和对照组的 C3(AUC 0.52)。

结论

我们的结果提供了一种改良的 C3dg 检测方法。我们证明,C3dg 在区分 SLE 患者与对照组方面优于传统的 C3 检测。我们建议 C3dg 应被视为 SLE 分类标准中的补体激活标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/a9f87af3afa3/fimmu-09-00581-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/fdb9db392a28/fimmu-09-00581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/14e205ea0cf4/fimmu-09-00581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/7a8de47bfdee/fimmu-09-00581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/b927724e1133/fimmu-09-00581-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/a9f87af3afa3/fimmu-09-00581-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/fdb9db392a28/fimmu-09-00581-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/14e205ea0cf4/fimmu-09-00581-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/7a8de47bfdee/fimmu-09-00581-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/b927724e1133/fimmu-09-00581-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/126c/5879092/a9f87af3afa3/fimmu-09-00581-g005.jpg

相似文献

1
The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.补体 C3dg 片段优于常规 C3 作为系统性红斑狼疮的诊断生物标志物。
Front Immunol. 2018 Mar 26;9:581. doi: 10.3389/fimmu.2018.00581. eCollection 2018.
2
Complement Receptor 2 Based Immunoassay Measuring Activation of the Complement System at C3-Level in Plasma Samples From Mice and Humans.基于补体受体 2 的免疫测定法,用于测量小鼠和人类血浆样本中补体系统在 C3 水平的激活情况。
Front Immunol. 2020 May 5;11:774. doi: 10.3389/fimmu.2020.00774. eCollection 2020.
3
Complement activation in human autoimmune diseases and mouse models; employing a sandwich immunoassay specific for C3dg.补体激活在人类自身免疫性疾病和小鼠模型中的作用;采用特异性针对 C3dg 的夹心免疫测定法。
J Immunol Methods. 2020 Nov;486:112866. doi: 10.1016/j.jim.2020.112866. Epub 2020 Sep 15.
4
Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease.在用于系统性红斑狼疮鉴别诊断及疾病患者监测的快速、廉价且易于操作的溶血补体检测中使用血清或缓冲液更换后的乙二胺四乙酸血浆。
Clin Vaccine Immunol. 2007 May;14(5):549-55. doi: 10.1128/CVI.00486-06. Epub 2007 Mar 7.
5
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.系统性红斑狼疮及其他涉及自身抗体和/或补体激活的疾病患者中与疾病相关的红细胞补体受体(CR1,C3b受体)缺失。
J Immunol. 1985 Sep;135(3):2005-14.
6
A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.一种用于检测六种不同形式免疫复合物的固相抗C3检测法。
J Immunol Methods. 1987 Apr 2;98(1):23-8. doi: 10.1016/0022-1759(87)90431-5.
7
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.补体激活与可能的系统性红斑狼疮患者向美国风湿病学会分类的系统性红斑狼疮的进展预测能力。
Arthritis Rheumatol. 2020 Jan;72(1):78-88. doi: 10.1002/art.41093. Epub 2019 Nov 25.
8
The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus.系统性红斑狼疮患者血浆中iC3b新抗原表达的临床意义。
Arthritis Rheum. 1989 Oct;32(10):1233-42. doi: 10.1002/anr.1780321008.
9
Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.尿新蝶呤作为系统性红斑狼疮患者疾病活动的一个参数:与血清可溶性白细胞介素-2受体、抗双链DNA抗体、红细胞沉降率以及血浆C3、C4和C3降解产物的比较
Ann Rheum Dis. 1993 Jun;52(6):429-35. doi: 10.1136/ard.52.6.429.
10
A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.一种通过检测C4-C3复合物来评估体内补体激活经典途径的新型酶联免疫吸附测定法。
J Immunol Methods. 1995 Oct 12;186(1):55-63. doi: 10.1016/0022-1759(95)00132-t.

引用本文的文献

1
Treat-To-Target: Emergence of Second-Generation CD40L Inhibitors for Treatment of SLE-Identifying Beneficial Patient Candidates for CD40L Inhibitors in a Cross-Sectional SLE Cohort.达标治疗:第二代CD40L抑制剂用于系统性红斑狼疮治疗的出现——在一个横断面系统性红斑狼疮队列中识别CD40L抑制剂的受益患者候选者
Scand J Immunol. 2025 Sep;102(3):e70050. doi: 10.1111/sji.70050.
2
Potential Biomarkers in Systemic Lupus Erythematosus.系统性红斑狼疮中的潜在生物标志物
JMA J. 2025 Jul 15;8(3):689-698. doi: 10.31662/jmaj.2025-0190. Epub 2025 Jul 7.
3
The relevance of complement levels in assessing the activity of lupus nephritis of different pathological types.

本文引用的文献

1
Lectin complement pathway proteins in healthy individuals.健康个体中的凝集素补体途径蛋白。
Clin Exp Immunol. 2017 Apr;188(1):138-147. doi: 10.1111/cei.12909. Epub 2017 Jan 18.
2
Complement in Lupus Nephritis: New Perspectives.狼疮性肾炎的补体:新视角。
Kidney Dis (Basel). 2015 Sep;1(2):91-9. doi: 10.1159/000431278. Epub 2015 Jun 30.
3
AMD and the alternative complement pathway: genetics and functional implications.年龄相关性黄斑变性与替代补体途径:遗传学及功能意义
补体水平在评估不同病理类型狼疮性肾炎活动度中的相关性。
Clin Rheumatol. 2025 Apr 7. doi: 10.1007/s10067-025-07429-5.
4
Lupus Nephritis Biomarkers: A Critical Review.狼疮性肾炎生物标志物:批判性综述。
Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805.
5
Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.阿米洛利减少肾小球蛋白尿中尿激酶/纤溶酶原驱动的管腔内补体激活。
J Am Soc Nephrol. 2024 Apr 1;35(4):410-425. doi: 10.1681/ASN.0000000000000312. Epub 2024 Jan 23.
6
Metalloporphyrins Reduce Proteinuria in Podocyte Immune Injury: The Role of Metal and Porphyrin Moieties.金属卟啉通过减轻足细胞免疫损伤减少蛋白尿:金属和卟啉部分的作用。
Int J Mol Sci. 2023 Aug 14;24(16):12777. doi: 10.3390/ijms241612777.
7
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus.区分系统性红斑狼疮患者通过凝集素途径或经典补体途径的激活。
Clin Exp Immunol. 2023 Dec 11;214(1):18-25. doi: 10.1093/cei/uxad070.
8
C3dg and MAC complement depositions in the renal histopathology of patients with lupus nephropathy.狼疮性肾炎患者肾脏组织病理学中的C3dg和膜攻击复合物补体沉积。
Transl Pediatr. 2023 Mar 31;12(3):320-330. doi: 10.21037/tp-22-310. Epub 2023 Mar 9.
9
Complement as a Biomarker for Systemic Lupus Erythematosus.补体作为系统性红斑狼疮的生物标志物。
Biomolecules. 2023 Feb 15;13(2):367. doi: 10.3390/biom13020367.
10
Distinction of early complement classical and lectin pathway activation quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs.采用新型 ELISA 技术对早期补体经典途径和凝集素途径激活进行区分——定量检测 C1s/C1-INH 和 MASP-1/C1-INH 复合物。
Front Immunol. 2022 Nov 4;13:1039765. doi: 10.3389/fimmu.2022.1039765. eCollection 2022.
Hum Genomics. 2016 Jun 21;10(1):23. doi: 10.1186/s40246-016-0079-x.
4
Quantitative Modeling of the Alternative Pathway of the Complement System.补体系统替代途径的定量建模
PLoS One. 2016 Mar 31;11(3):e0152337. doi: 10.1371/journal.pone.0152337. eCollection 2016.
5
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.人类系统性自身免疫性疾病中补体经典激活途径的早期成分
Front Immunol. 2016 Feb 15;7:36. doi: 10.3389/fimmu.2016.00036. eCollection 2016.
6
Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.东亚人群补体 C4 基因拷贝数变异、大小二分体和 C4A 缺乏对系统性红斑狼疮遗传风险和临床表现的影响。
Arthritis Rheumatol. 2016 Jun;68(6):1442-1453. doi: 10.1002/art.39589.
7
Complement activation, regulation, and molecular basis for complement-related diseases.补体激活、调节及补体相关疾病的分子基础。
EMBO J. 2015 Nov 12;34(22):2735-57. doi: 10.15252/embj.201591881. Epub 2015 Oct 21.
8
Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.狼疮性肾炎患者中抗补体成分C3自身抗体的功能特性
J Biol Chem. 2015 Oct 16;290(42):25343-55. doi: 10.1074/jbc.M115.647008. Epub 2015 Aug 5.
9
Complement System Part I - Molecular Mechanisms of Activation and Regulation.补体系统 第一部分——激活与调节的分子机制
Front Immunol. 2015 Jun 2;6:262. doi: 10.3389/fimmu.2015.00262. eCollection 2015.
10
Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.阵发性夜间血红蛋白尿症:一种补体介导的溶血性贫血。
Hematol Oncol Clin North Am. 2015 Jun;29(3):479-94. doi: 10.1016/j.hoc.2015.01.005. Epub 2015 Mar 7.